Skip to main content

CombiMatrix Taps Cartagenia to Provide Microarray Data Analysis Software


Cartagenia said this week that CombiMatrix, an Irvine, Calif.-based molecular diagnostics firm, has selected its Bench lab software for copy number variant analysis.

CombiMatrix will use the software to handle microarray data analysis, interpretation, and reporting for its postnatal and prenatal testing service.

Cartagenia said that it will tailor the software to CombiMatrix's variant assessment and reporting workflow so that the company can perform interpretation and reporting without having to disrupt its established operating procedures. Additionally, Cartagenia will also integrate the software with existing information technology systems at CombiMatrix.

Richard Hockett, CombiMatrix’s chief medical officer, explained that the company selected Cartagenia’s software because the company “clearly positions its solutions for clinical use," which is "in contrast to other software packages.”

Furthermore, "with our lab operations and test volumes growing, it made perfect sense to select the Cartagenia Bench platform at this time,” he said in a statement.

“We already perform hundreds of microarray analyses per month and having recently expanded testing for the prenatal marketplace, that number will grow even more,” Hockett explained. “The automation provided by Bench lab CNV gives us the ability to grow our array throughput while providing significant savings in both analysis and interpretation time and staffing.”

In addition to CombiMatrix, Cartagenia’s client list includes Credit Valley Hospital lab, an Ontario-based clinical cytogenetic laboratory (BI 5/18/2012), as well as Gene DX and the Los Angeles Children’s Hospital (BI 3/23/2012).

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.